PeakXV has sold its shareholding in La Renon Healthcare Private Limited to Creador Group, White Oak Group and Siguler Guff. Creador Group invested ₹800 crore in La Renon as a part of this transaction.

TT&A advised PeakXV on this transaction.

The transaction team consisted of Dushyant Bagga (Partner), Garvita Mehrotra (Managing Associate) and Prerna Raturi (Senior Associate).

JSA Advocates & Solicitors advised La Renon Healthcare on this transaction.

The transaction team was led by Sidharrth Shankar (Partner) with support from Nandini Seth (Partner), Aditya Vardhan Dayal (Principal Associate), Pranav Rao (Senior Associate) and Achint Johri (Associate).

Nisha Kaur Uberoi (Partner & Chair Competition Law), Pranav Satyam (Partner), Kamal Sharma (Senior Associate) and Associates Mayank Gandhi and Tarun Katariya advised on Competition Law aspects.

Veritas Legal acted for and advised Creador on this transaction. The Firm's corporate team worked on the legal due diligence, drafting and negotiating transaction documents and assisted with the closing formalities, while the Firm's Competition law team advised and represented the client in obtaining an unconditional approval from the Competition Commission of India for the transaction.

The Firm's team consisted of Manav Raheja (Senior Partner - Corporate), Zenia Cassinath (Partner - Competition), Swapnil Phadnis (Principal Associate), Associates Kapeesh Grover, Aryan Mehta, Ishan Mhapsekar, Rahil Shah, Abhay, Aagam Shah, Afrrin Advani, Kritvi Kumar, Dhruv Mehta, and Harshita Kushwah.

AZB & Partners advised Siguler Guff on this transaction.

La Renon Healthcare Pvt. Ltd. is recognized as one of the top 50 pharmaceutical companies in India. The company focuses on key therapeutic areas such as nephrology, critical care, neurology, and cardiac metabolism.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.